(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CAJAL NEUROSCIENCE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CAJAL NEUROSCIENCE

ST13

US500000090275625

Class

42, 44

Filing

90275625

Registration

7507956

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

53

Latest update

08/13/2026

Trademark type

Combined

Nice classes

42, 44

Filing date

10/23/2020

Registration date

09/17/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/17/2024

Last transaction

08/13/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2022-09-00

First use in commerce

2022-09-00

Drawing code

3

Owner type

03

Owner location

SEATTLE, WA, US

Examiner

CIURPITA, DREW PETER FISHER

Current location

Historical data usage

Mark description

The mark consists of a design of a brain neuron inside of a circle with the phrase "CAJAL NEUROSCIENCE" to the right.

Holders and representatives

Holders

CAJAL THERAPEUTICS INC.
Cajal Neuroscience Inc.

Representatives

Brandon P. Leahy WILSON SONSINI GOODRICH & ROSATI

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

providing medical and scientific research information in the field of pharmaceuticals and neurodegenerative disorders

Class 44

providing medical information in the field of pharmaceuticals and neurodegenerative disorders; providing a website featuring medical information in the fields of pharmaceuticals and neurodegenerative disorders

Publications

History of USPTO decisions and trademark events.

53 publications found

WDRL

OTQR WITHDRAWAL FROM PUBLICATION

08/13/2026

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

06/26/2026

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

06/11/2026

PRAM

POST REGISTRATION ACTION MAILED - SEC. 7

04/30/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/27/2026

WDRL

OTQR WITHDRAWAL FROM PUBLICATION

04/08/2026

XXXX

POST REGISTRATION ACTION CORRECTION

02/12/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/09/2026

ES7R

TEAS SECTION 7 REQUEST RECEIVED

10/30/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/22/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/22/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/18/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/17/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

09/17/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/12/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/12/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/17/2024

IUAF

USE AMENDMENT FILED

06/14/2024

EISU

TEAS STATEMENT OF USE RECEIVED

06/14/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/02/2023

EX5G

SOU EXTENSION 5 GRANTED

12/01/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/01/2023

EXT5

SOU EXTENSION 5 FILED

11/20/2023

EEXT

SOU TEAS EXTENSION RECEIVED

11/20/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/02/2023

EX4G

SOU EXTENSION 4 GRANTED

04/28/2023

EXT4

SOU EXTENSION 4 FILED

04/28/2023

EEXT

SOU TEAS EXTENSION RECEIVED

04/28/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/27/2022

EX3G

SOU EXTENSION 3 GRANTED

10/25/2022

EXT3

SOU EXTENSION 3 FILED

10/25/2022

EEXT

SOU TEAS EXTENSION RECEIVED

10/25/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/10/2022

EX2G

SOU EXTENSION 2 GRANTED

05/06/2022

EXT2

SOU EXTENSION 2 FILED

05/06/2022

EEXT

SOU TEAS EXTENSION RECEIVED

05/06/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/07/2021

EX1G

SOU EXTENSION 1 GRANTED

08/05/2021

EXT1

SOU EXTENSION 1 FILED

08/05/2021

EEXT

SOU TEAS EXTENSION RECEIVED

08/05/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/29/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/04/2021

PUBO

PUBLISHED FOR OPPOSITION

05/04/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/14/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/29/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

03/29/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/29/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

03/29/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/29/2021

DOCK

ASSIGNED TO EXAMINER

03/24/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/15/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/14/2020

NWAP

NEW APPLICATION ENTERED

10/27/2020

Continuous trademark protection

Get notified about every new filing that threatens CAJAL NEUROSCIENCE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.